208 related articles for article (PubMed ID: 31451839)
41. Quantitative dynamic contrast-enhanced MR imaging for the preliminary prediction of the response to gemcitabine-based chemotherapy in advanced pancreatic ductal carcinoma.
Tang W; Liu W; Li HM; Wang QF; Fu CX; Wang XH; Zhou LP; Peng WJ
Eur J Radiol; 2019 Dec; 121():108734. PubMed ID: 31743881
[TBL] [Abstract][Full Text] [Related]
42. Preoperative histogram parameters of dynamic contrast-enhanced MRI as a potential imaging biomarker for assessing the expression of Ki-67 in prostate cancer.
Zhang Y; Li Z; Gao C; Shen J; Chen M; Liu Y; Cao Z; Pang P; Cui F; Xu M
Cancer Med; 2021 Jul; 10(13):4240-4249. PubMed ID: 34117733
[TBL] [Abstract][Full Text] [Related]
43. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for pretreatment prediction of neoadjuvant chemotherapy response in locally advanced hypopharyngeal cancer.
Guo W; Zhang Y; Luo D; Yuan H
Br J Radiol; 2020 Nov; 93(1115):20200751. PubMed ID: 32915647
[No Abstract] [Full Text] [Related]
44. Comparison of Intravoxel incoherent motion imaging and multiecho dynamic contrast-based MRI in rectal cancer.
Bakke KM; Grøvik E; Meltzer S; Negård A; Holmedal SH; Mikalsen LTG; Lyckander LG; Ree AH; Gjesdal KI; Redalen KR; Bjørnerud A
J Magn Reson Imaging; 2019 Oct; 50(4):1114-1124. PubMed ID: 30945379
[TBL] [Abstract][Full Text] [Related]
45. Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using Pharmacokinetic Modeling: Initial Experience in Patients With Early Arthritis.
Maijer KI; van der Leij C; de Hair MJ; Tas SW; Maas M; Gerlag DM; Tak PP; Lavini C
Arthritis Rheumatol; 2016 Mar; 68(3):587-96. PubMed ID: 26473331
[TBL] [Abstract][Full Text] [Related]
46. Assessment of esophageal carcinoma undergoing concurrent chemoradiotherapy with quantitative dynamic contrast-enhanced magnetic resonance imaging.
Lei J; Han Q; Zhu S; Shi D; Dou S; Su Z; Xu X
Oncol Lett; 2015 Dec; 10(6):3607-3612. PubMed ID: 26788177
[TBL] [Abstract][Full Text] [Related]
47. Enhancement degree of brain metastases: correlation analysis between enhanced T2 FLAIR and vascular permeability parameters of dynamic contrast-enhanced MRI.
Jin T; Zhang H; Liu X; Kong X; Makamure J; Chen Z; Alwalid O; Yao Z; Wang J
Eur Radiol; 2021 Aug; 31(8):5595-5604. PubMed ID: 33847812
[TBL] [Abstract][Full Text] [Related]
48. Can Dynamic Contrast-Enhanced MRI (DCE-MRI) and Diffusion-Weighted MRI (DW-MRI) Evaluate Inflammation Disease: A Preliminary Study of Crohn's Disease.
Zhu J; Zhang F; Luan Y; Cao P; Liu F; He W; Wang D
Medicine (Baltimore); 2016 Apr; 95(14):e3239. PubMed ID: 27057860
[TBL] [Abstract][Full Text] [Related]
49. [The value of DCE-MRI in predicting IDH gene mutation of high-grade gliomas].
Lu HT; Xing W; Zhang YW; Qin HP; Wu RH; Ding JL
Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(39):3105-3109. PubMed ID: 31648456
[No Abstract] [Full Text] [Related]
50. Dynamic contrast-enhanced MRI: Study of inter-software accuracy and reproducibility using simulated and clinical data.
Beuzit L; Eliat PA; Brun V; Ferré JC; Gandon Y; Bannier E; Saint-Jalmes H
J Magn Reson Imaging; 2016 Jun; 43(6):1288-300. PubMed ID: 26687041
[TBL] [Abstract][Full Text] [Related]
51. Use of biexponential and stretched exponential models of intravoxel incoherent motion and dynamic contrast-enhanced magnetic resonance imaging to assess the proliferation of endometrial carcinoma.
Zhang G; Yan R; Liu W; Jin X; Wang X; Wang H; Li Z; Shang J; Wang K; Guo J; Han D
Quant Imaging Med Surg; 2023 Apr; 13(4):2568-2581. PubMed ID: 37064373
[TBL] [Abstract][Full Text] [Related]
52. Quantitative dynamic contrast-enhanced MR imaging for differentiating benign, borderline, and malignant ovarian tumors.
Li HM; Feng F; Qiang JW; Zhang GF; Zhao SH; Ma FH; Li YA; Gu WY
Abdom Radiol (NY); 2018 Nov; 43(11):3132-3141. PubMed ID: 29556691
[TBL] [Abstract][Full Text] [Related]
53. Inter- and intra-rater reproducibility of quantitative dynamic contrast enhanced MRI using TWIST perfusion data in a uterine fibroid model.
Davenport MS; Heye T; Dale BM; Horvath JJ; Breault SR; Feuerlein S; Bashir MR; Boll DT; Merkle EM
J Magn Reson Imaging; 2013 Aug; 38(2):329-35. PubMed ID: 23239041
[TBL] [Abstract][Full Text] [Related]
54. Application of Dynamic Enhanced Magnetic Resonance Imaging Texture Analysis Combined with ADCs in Predicting Pelvic Lymph Metastasis of Prostate Cancer.
Yao L; Ding J; Li X; Yang J; Chen Z; Jia C; Duan Q
Arch Esp Urol; 2023 Aug; 76(6):383-388. PubMed ID: 37681328
[TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetic analysis for the differentiation of pituitary microadenoma subtypes through dynamic contrast-enhanced magnetic resonance imaging.
Zhai J; Zheng W; Zhang Q; Wu J; Zhang X
Oncol Lett; 2019 May; 17(5):4237-4244. PubMed ID: 30944618
[TBL] [Abstract][Full Text] [Related]
56. Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging in patients with rectal cancer: correlation with microvascular density and vascular endothelial growth factor expression.
Kim YE; Lim JS; Choi J; Kim D; Myoung S; Kim MJ; Kim KW
Korean J Radiol; 2013; 14(6):878-85. PubMed ID: 24265562
[TBL] [Abstract][Full Text] [Related]
57. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of Mesorectal Microcirculation With Quantitative Dynamic Contrast-Enhanced MRI.
Yang X; Liu Y; Chen Y; Wen Z; Lin B; Quan X; Yu S
AJR Am J Roentgenol; 2020 Dec; 215(6):1370-1376. PubMed ID: 32991218
[No Abstract] [Full Text] [Related]
59. Standard diffusion-weighted, intravoxel incoherent motion, and dynamic contrast-enhanced MRI of musculoskeletal tumours: correlations with Ki67 proliferation status.
Zhan J; Hao D; Wang D; Yue B; Zhou R; Tian N; Liu M; Gao C; Xu W; Cui J
Clin Radiol; 2021 Dec; 76(12):941.e11-941.e18. PubMed ID: 34579866
[TBL] [Abstract][Full Text] [Related]
60. Quantitative parameters of magnetic resonance imaging cannot predict human epidermal growth factor receptor 2 (HER2) status in rectal cancer.
Huang Z; Tu X; Lin Q; Zhan Z; Li Y; Liu J
Clin Imaging; 2022 Mar; 83():77-82. PubMed ID: 34990984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
